Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two milli...

全面介紹

Saved in:
書目詳細資料
Main Authors: Thomas F. Baumert, Steven K.H. Foung
格式: Online
語言:英语
出版: Frontiers Media SA 2021
主題:
在線閱讀:32082
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
_version_ 1869529904443293696
author Thomas F. Baumert
Steven K.H. Foung
author_browse Steven K.H. Foung
Thomas F. Baumert
author_facet Thomas F. Baumert
Steven K.H. Foung
author_sort Thomas F. Baumert
collection Directory of Open Access Books
description More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two million new infections per year, mainly due to injection drug use. An effective vaccine will be the most effective means to contain the spread of this virus worldwide. The articles in this Research Topic describe the progress that has been made towards a preventive vaccine and the challenges that still need to be overcome to ultimately achieve this goal.
format Online
id doab-20.500.12854ir-44424
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Frontiers Media SA
publisherStr Frontiers Media SA
record_format ojs
spelling doab-20.500.12854ir-444242024-03-31T13:10:11Z Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine Thomas F. Baumert Steven K.H. Foung R5-920 RC581-607 Conformational epitopes humoral immunity Conformational structures neutralizing antibodies Vaccine Hepatitis C virus hypervariability and flexibility thema EDItEUR::M Medicine and Nursing More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two million new infections per year, mainly due to injection drug use. An effective vaccine will be the most effective means to contain the spread of this virus worldwide. The articles in this Research Topic describe the progress that has been made towards a preventive vaccine and the challenges that still need to be overcome to ultimately achieve this goal. 2021-02-11T10:53:28Z 2021-02-11T10:53:28Z 2019-01-23 14:53:43 2019 book 32082 16648714 9782889457144 https://directory.doabooks.org/handle/20.500.12854/44424 eng Frontiers Research Topics image/jpeg Attribution 4.0 International https://www.frontiersin.org/research-topics/6604/current-progress-and-challenges-in-the-development-of-a-b-cell-based-hepatitis-c-virus-vaccine Frontiers Media SA 10.3389/978-2-88945-714-4 10.3389/978-2-88945-714-4 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889457144 128 open access
spellingShingle R5-920
RC581-607
Conformational epitopes
humoral immunity
Conformational structures
neutralizing antibodies
Vaccine
Hepatitis C virus
hypervariability and flexibility
thema EDItEUR::M Medicine and Nursing
Thomas F. Baumert
Steven K.H. Foung
Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_full Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_fullStr Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_full_unstemmed Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_short Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_sort current progress and challenges in the development of a hepatitis c virus vaccine
topic R5-920
RC581-607
Conformational epitopes
humoral immunity
Conformational structures
neutralizing antibodies
Vaccine
Hepatitis C virus
hypervariability and flexibility
thema EDItEUR::M Medicine and Nursing
topic_facet R5-920
RC581-607
Conformational epitopes
humoral immunity
Conformational structures
neutralizing antibodies
Vaccine
Hepatitis C virus
hypervariability and flexibility
thema EDItEUR::M Medicine and Nursing
url 32082
work_keys_str_mv AT thomasfbaumert currentprogressandchallengesinthedevelopmentofahepatitiscvirusvaccine
AT stevenkhfoung currentprogressandchallengesinthedevelopmentofahepatitiscvirusvaccine